FDA Drug Application (090704) for CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE by MYLAN LABS

Back to FDA Applications sponsored by MYLAN LABS

Application Number090704
Product Number001
FormTABLET;ORAL
Dosage16MG;12.5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameCANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE
Active IngredientCANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE



Back to FDA Applications sponsored by MYLAN LABS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.